CN100455322C - A Chinese medicine for treating cancer - Google Patents

A Chinese medicine for treating cancer Download PDF

Info

Publication number
CN100455322C
CN100455322C CNB2006100127366A CN200610012736A CN100455322C CN 100455322 C CN100455322 C CN 100455322C CN B2006100127366 A CNB2006100127366 A CN B2006100127366A CN 200610012736 A CN200610012736 A CN 200610012736A CN 100455322 C CN100455322 C CN 100455322C
Authority
CN
China
Prior art keywords
chinese medicine
portions
parts
chinese
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB2006100127366A
Other languages
Chinese (zh)
Other versions
CN1879842A (en
Inventor
郭富红
郭志军
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB2006100127366A priority Critical patent/CN100455322C/en
Publication of CN1879842A publication Critical patent/CN1879842A/en
Application granted granted Critical
Publication of CN100455322C publication Critical patent/CN100455322C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a Chinese medicine for treating tumors, which belongs to medicines for treating cancer tumors, more specifically a Chinese medicinal medicament prepared by using Chinese herbal medicines as raw materials. The Chinese medicine mainly has the technical characteristic that the Chinese medicine is prepared from the following raw materials according to a proportion by weight: 6 to 15 portions of burdock seed, 6 to 15 portions of vietnamese sophora root, 3 to 6 portions of Indian iphigenia bulb, 10 to 15 portions of zedoary and 10 to 20 portions of ganoderma. The Chinese medicine can effectively suppress the growth of cancer cells, effectively prevent the transfer and the relapse of cancer tumors and achieve the goal of healing.

Description

A kind of Chinese medicine for the treatment of tumor
Technical field
The invention belongs to a kind of medicine for the treatment of tumor, specifically is the Chinese drugs agentia of feedstock production with the Chinese herbal medicine.
Background technology
Tumor is a disease that is difficult to treat at the clinical medicine category, and prior treatment method adopts excision mostly, carries out the method for chemotherapy again.Above-mentioned treatment brings very big misery to the patient, but is difficult to reach healing.Numerous medical personnels are at the effective ways of studying intensively, seek treatment, but the present medicament that does not also have effectively to cure tumor.
Summary of the invention
Of the present inventionly provide a kind of Chinese medicine for the treatment of tumor, the effectively growth of anticancer prevents that effectively tumor from shifting and recurrence, reaches the purpose of healing.
Medicine of the present invention is formed (consumption is a weight portion) by following component:
Fructus Arctii (the other son of cattle) 6-15 part, Radix Sophorae Tonkinensis 6-15 part, Pseudobulbus Cremastrae Seu Pleiones 3-6 part, Rhizoma Curcumae 10-15 part, Ganoderma 10-20 part.
The formula optimization weight proportion scope of preparation medicine of the present invention is:
Fructus Arctii (the other son of cattle) 8-13 part, Radix Sophorae Tonkinensis 8-14 part, Pseudobulbus Cremastrae Seu Pleiones 4-5 part, Rhizoma Curcumae 11-13 part, Ganoderma 13-16 part.
The optimum weight proportioning of medicine of the present invention is:
10 parts of Fructus Arctiis (the other son of cattle), 10 parts of Radix Sophorae Tonkinensiss, 5 parts of Pseudobulbus Cremastrae Seu Pleioness, 12 parts of Rhizoma Curcumae, 15 parts of Ganodermas.
Pharmacology analysis:
Fructus Arctii (the other son of cattle): contain Fructus Arctii (by the cattle), fatty oil, vitamin A, vitamin B and alkaloid etc.Fructus Arctii (the other son of cattle) decoct has analgesic diuretic actions; Recent findings Fructus Arctii (the other son of cattle) has antitumor action; Its crude extract is selection toxicity, and low amount just can be bred by anticancer, makes tumor cell approaching to normal cell.
Radix Sophorae Tonkinensis: contain matrine, oxymatrine, bean curd with odor and methylcytisine also contain multiple flavone compound in addition, as pterocarpin, red east axle grass etc.Root of subprostrate sophora has antitumaous effect, and contained oxymatrine all is inhibitory action to 180 yoshida sarcomas, ascites hepatocarcinoma tumor.
Pseudobulbus Cremastrae Seu Pleiones: the mucous and glucose of Cuculus polioephalus rhizome is joined the mannitol polysaccharide.Synthetic NSC-3096 behind contained autumn waters--limid eyes alkali of Pseudobulbus Cremastrae Seu Pleiones Tulipa edulis and iphigenia indica and the adding ammonia thereof all has the antitumor action similar to vinblastine.
Rhizoma Curcumae contains volatile oil, wherein mainly is the Rhizoma Curcumae paulownia, curzerene, curcumin etc., and isolating the two alcohol of anticancer main component curcumenol, Rhizoma Curcumae from volatile oil has antitumaous effect, also can make the place live specific immune function and strengthen, and obtains tangible immunoprotection effect.
Ganoderma: also have selenic composition in the Ganoderma, selenium kills tumor and can not hurt sb.'s feelings, and through evidence, selenium is not only stared at and killed fixed tumor cell, but also can remove free tumor cell in the blood, the transfer and the recurrence of having stopped tumor everywhere.
Said herbal medicine according to formula compatibility of the present invention, can be played the anticancer growth, and the transfer and the recurrence of stopping cancerous cell are stared at and are killed fixed tumor cell, thereby cure cancer.
The specific embodiment
After medicine of the present invention makes according to set of dispense, can take by fried according to a conventional method one-tenth decoction, also can manufacture the Chinese medicine pill according to a conventional method, the Chinese medicine electuary is taken, can also daily dosage effective component extracting according to Chinese herbal medicine after, make capsule and quantitatively take on time.
The present invention takes medicine one week of back through clinical practice, and tumor is obviously dwindled, and expands to suppress pain and obviously reduce, and then goes down day by day, decides on state of an illness weight, and there are positive effect or healing 10-30 day.Adopt prescription treatment cancerous protuberance 30 examples of the present invention, cure rate 58%, effective percentage are imitated and are reached 90%.
Model case: Lee * *, the woman, 40 years old, to suffer from the lymph node tumor in July, 2003 and done to recur again after the operation, tuberosity appears again in cervical region.Take the fried decoction of Chinese medicine of the present invention, one day twice, sooner or later service once, lump dwindles after 3 days, and whole body has comfortable sensation; Tumor disappears after taking medicine 7.Observe year nothing recurrence half a year to one continuously.

Claims (3)

1, a kind of Chinese medicine for the treatment of tumor is characterized in that it is the medicament of being made by the following weight proportion raw material: Fructus Arctii 6-15 part, Radix Sophorae Tonkinensis 6-15 part, Pseudobulbus Cremastrae Seu Pleiones 3-6 part, Rhizoma Curcumae 10-15 part, Ganoderma 10-20 part.
2, the Chinese medicine of treatment tumor according to claim 1 is characterized in that: wherein the weight proportion of each raw material is: Fructus Arctii 8-13 part, Radix Sophorae Tonkinensis 8-14 part, Pseudobulbus Cremastrae Seu Pleiones 4-5 part, Rhizoma Curcumae 11-13 part, Ganoderma 13-16 part.
3, the Chinese medicine of treatment tumor according to claim 1 is characterized in that: wherein the weight proportion of each raw material is: 10 parts of Fructus Arctiis, 10 parts of Radix Sophorae Tonkinensiss, 5 parts of Pseudobulbus Cremastrae Seu Pleioness, 12 parts of Rhizoma Curcumae, 15 parts of Ganodermas.
CNB2006100127366A 2006-05-17 2006-05-17 A Chinese medicine for treating cancer Expired - Fee Related CN100455322C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2006100127366A CN100455322C (en) 2006-05-17 2006-05-17 A Chinese medicine for treating cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2006100127366A CN100455322C (en) 2006-05-17 2006-05-17 A Chinese medicine for treating cancer

Publications (2)

Publication Number Publication Date
CN1879842A CN1879842A (en) 2006-12-20
CN100455322C true CN100455322C (en) 2009-01-28

Family

ID=37518343

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2006100127366A Expired - Fee Related CN100455322C (en) 2006-05-17 2006-05-17 A Chinese medicine for treating cancer

Country Status (1)

Country Link
CN (1) CN100455322C (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102266434B (en) * 2011-08-05 2013-04-10 暨南大学 Chinese medicinal composition for resisting tumor metastasis and preparation method thereof
CN108379508A (en) * 2018-03-15 2018-08-10 陆海燕 A kind of composition that treating tumour and its preparation and application and application
CN108619452A (en) * 2018-05-18 2018-10-09 杜美丽 It a kind of Chinese medicine composition that treating tumour and follows through permeabilization therapy
CN111184815A (en) * 2020-02-24 2020-05-22 杭州憶盛医疗科技有限公司 Anti-tumor injection for treating lymphosarcoma and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1483423A (en) * 2002-09-19 2004-03-24 于天德 Traditional Chinese medicine for treating cancer and preparation method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1483423A (en) * 2002-09-19 2004-03-24 于天德 Traditional Chinese medicine for treating cancer and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
中医抗癌处方组成探析. 徐力等.江苏中医药,第24卷第12期. 2003
中医抗癌处方组成探析. 徐力等.江苏中医药,第24卷第12期. 2003 *

Also Published As

Publication number Publication date
CN1879842A (en) 2006-12-20

Similar Documents

Publication Publication Date Title
CN102091315A (en) Ginger and dark plum fruit composition and preparation method thereof, and application of ginger and dark plum fruit composition in preparation of attenuation and synergy medicaments for radiotherapy and chemotherapy of cancers
CN102727706A (en) Composition for preventing and treating diabetes
CN102008650B (en) Compound traditional Chinese medicine preparation for treating tumors and preparation method thereof
CN101856384B (en) Liver-protecting combination
CN100455322C (en) A Chinese medicine for treating cancer
KR101826737B1 (en) A composition containing herbs extract, and manufacturing method of the same
CN102861193B (en) Traditional Chinese medicine composition for treating gastric cancer
CN103908611A (en) Traditional Chinese medicine preparation for treating colon cancer and preparation method of traditional Chinese medicine preparation
US20230125425A1 (en) Traditional chinese medicine extract composition with function of regulating depressive emotion and preparation method and traditional chinese medicine preparation thereof
CN106176787B (en) The application and drug of forsythin, Fructus Forsythiae glycoside derivates, forsythin and phillygenol composition in preparation anticancer or anti-tumor drug
CN103550718B (en) A kind of Chinese medicine composition for the treatment of pulmonary carcinoma
CN107496525A (en) A kind of Chinese medicine composition for treating cancer pain disease and its application
CN102895387A (en) Kidney-yang-warming medicine composition, and preparation thereof and preparation method thereof
CN102423384B (en) Traditional Chinese drug preparation for treating lung cancer, and preparation method thereof
CN101584750B (en) Compound fig preparation
CN102813873A (en) Traditional Chinese medicine composition for treating mental diseases, and preparation method, application and quality control thereof
CN112220846A (en) Traditional Chinese medicine composition for treating children's chronic cough and application thereof
CN105596889A (en) Antitumor composition containing resveratrol and preparation method of antitumor composition
CN104491677A (en) Preparation method of medicament for treating sexual dysfunction
CN105169149A (en) Traditional Chinese medicine composition for treating pyrophlegm stasis accumulation type thyroid cancer, preparation method and application
CN104352994A (en) Pharmaceutical preparation for sexual dysfunction
CN104223066A (en) Traditional Chinese medicine composition for improving sleeping
CN103989714A (en) Pharmaceutical composition with antitumor effect and preparation of pharmaceutical composition
CN103520684A (en) Traditional Chinese medicine compound for reducing blood sugar
CN102178221B (en) Cordyceps militaris composite nutrition composition capable of improving defecation function and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20090128

Termination date: 20140517